Mitral Valve Prolapse Arrhythmic Risk
NCT07830888
Summary
Mitral valve prolapse (MVP) is common with a 2-3 % prevalence in the general association and generally associated with a favorable prognosis. However, a subgroup of MVP patients, known as arrhythmic mitral valve prolapse (AMVP) has an increased burden of severe ventricular arrhythmias and risk of sudden cardiac death. Identifying high risk patients who may benefit of potential implantable cardioverter-defibrillator (ICD) implantation is therefore critically important. Risk stratification in AMVP is still challenging, and the ability to estimate arrhythmic risk at the individual level is limited.
Eligibility
Inclusion Criteria: * MVP according to the ESC definition AND * Arrhythmic burden of: * A total PVC burden ≥ 0,5 % per day OR * Documentation of NSVT on any modality OR * More severe ventricular arrhythmias (sustained ventricular tachycardia, ventricular fibrillation, aborted cardiac arrest) that occurred \>1 month after the beginning of follow up. AND \- Follow up \>6 months Exclusion Criteria: * VT/VF as the initial presentation without prior cardiac evaluation (ECG, echo, Holter) * History of myocardial infarction * Obstructive coronary diseases - ≥50 % stenosis that was not treated * History of coronary artery bypass surgery * Significant valve disease other than MVP - rheumatic heart disease, severe aortic stenosis * LGE suggestive of probable myocarditis as the etiology. * Primary inherited arrhythmia - Brugada syndrome, short QT, long QT, CPVT * Carrier of disease causing mutation known to be associated with arrhythmia even when phenotype is negative (e.g. Lamin A/C) * Sustained ventricular arrhythmia clearly caused by a reversable cause
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07830888